New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
In the immediate aftermath, estimating the numbers affected by a breast screening error might do more harm than good.
With new cancer detection technology on the horizon, ranging from blood tests to wristbands, understanding overdiagnosis is a huge challenge.
Our researchers have discovered a way to halt breast cancer spread in mice, by blocking a molecule called asparagine. But what does this mean for patients?
Category: Science blog November 24, 2017
The START trials provided the evidence needed to change practice for women having radiotherapy to treat breast cancer.
Category: Science blog October 26, 2017
A world-first data report could help us understand whether cancer patients are getting the most appropriate treatments for them.
The growing global cost of obesity was in the news this week, along with genetic tests for breast cancer and a rare childhood cancer.
The good news is there’s no reason to be concerned about deodorants, bras, plastics and milk when it comes to breast cancer risk.
The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.